📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Idorsia

1.1 - Company Overview

Idorsia Logo

Idorsia

Headquarter: Switzerland
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of innovative biopharmaceutical therapies and resources, including daridorexant (QUVIVIQ), a dual orexin receptor antagonist for chronic insomnia, aprocitentan (TRYVIO/JERAYGO), an oral dual endothelin receptor antagonist for resistant hypertension, and a medical information and educational portal for healthcare professionals and patients.

Products and services

  • Aprocitentan (TRYVIO/JERAYGO): An orally active dual endothelin receptor antagonist that treats resistant hypertension by inhibiting ET-1 binding to ETA and ETB receptors
  • Daridorexant (QUVIVIQ): A dual orexin receptor antagonist used to treat chronic insomnia by selectively blocking orexin receptors to reduce wakefulness
  • Medical Information and Educational Resources Portal: A scientific information and educational resources platform that delivers content for healthcare professionals and patients

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Idorsia

Coley Pharmaceutical Logo

Coley Pharmaceutical

HQ: United States Website
  • Description: Provider of biopharmaceutical therapeutics and drug candidates that direct the human immune system to fight cancers, asthma, allergy, and autoimmune disorders, and to enhance the effectiveness of vaccines.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Coley Pharmaceutical company profile →
InnoPharma Logo

InnoPharma

HQ: United States Website
  • Description: Provider of niche-generic, specialty pharmaceutical and bio-pharmaceutical product development, operating as a privately held pharmaceutical R&D company founded in 2005 and based in Piscataway, New Jersey.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full InnoPharma company profile →
Lewis and Clark Pharmaceuticals Logo

Lewis and Clark Pharmaceuticals

HQ: United States Website
  • Description: Provider of early-stage pharmaceutical development targeting treatments for arthritis, diabetes, glaucoma, and atherosclerosis.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Lewis and Clark Pharmaceuticals company profile →
Chronos Therapeutics Logo

Chronos Therapeutics

HQ: United Kingdom Website
  • Description: Provider of age-related disease drug development, advancing SFX-01, a sulforaphane-based stable tablet for oncology and neurodevelopmental disorders; a highly selective orexin 1 receptor antagonist for addictive behaviors including binge eating disorder and alcohol use disorder; and an atypical DAT inhibitor for fatigue and narcolepsy, plus licensing and partnership collaborations.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Chronos Therapeutics company profile →
UPSA Logo

UPSA

HQ: France Website
  • Description: Provider of pharmaceuticals, food supplements, and medical devices for the fight against pain and self-medication, serving patients from infants to seniors.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full UPSA company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Idorsia

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Idorsia

2.2 - Growth funds investing in similar companies to Idorsia

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Idorsia

4.2 - Public trading comparable groups for Idorsia

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Idorsia

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Idorsia

What does Idorsia do?

Idorsia is a provider of innovative biopharmaceutical therapies and resources, including daridorexant (QUVIVIQ), a dual orexin receptor antagonist for chronic insomnia, aprocitentan (TRYVIO/JERAYGO), an oral dual endothelin receptor antagonist for resistant hypertension, and a medical information and educational portal for healthcare professionals and patients.

Who are Idorsia's competitors?

Idorsia's competitors and similar companies include Coley Pharmaceutical, InnoPharma, Lewis and Clark Pharmaceuticals, Chronos Therapeutics, and UPSA.

Where is Idorsia headquartered?

Idorsia is headquartered in Switzerland.

How many employees does Idorsia have?

Idorsia has 1,000 employees 🔒.

When was Idorsia founded?

Idorsia was founded in 2010 🔒.

What sector and industry vertical is Idorsia in?

Idorsia is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Idorsia

Who are the top strategic acquirers in Idorsia's sector and industry

Top strategic M&A buyers and acquirers in Idorsia's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Idorsia?

Top strategic M&A buyers groups and sectors for Idorsia include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Idorsia's sector and industry vertical

Which are the top PE firms investing in Idorsia's sector and industry vertical?

Top PE firms investing in Idorsia's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Idorsia's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Idorsia's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Idorsia's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Idorsia include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Idorsia's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Idorsia?

The key public trading comparables and valuation benchmarks for Idorsia include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Idorsia for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Idorsia with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Idorsia's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Idorsia with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Idorsia's' sector and industry vertical?

Access recent funding rounds and capital raises in Idorsia's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Idorsia